MTOR and melanoma: Another compound under study in models of melanoma is SKLB-M8, a millepaquine derivative, which appears to block cell proliferation via the AKT/mTOR pathway and appears to down-regulate angiogenesis by regulating ERK1/2 phosphorylation [74].